CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences: Guggenheim's Inaugural Healthcare ...

Getting an annual flu shot can be stressful for some people — especially those with autism, fragile X syndrome, ADHD and other neurodevelopmental disabilities. That’s where a specialized, seasonal ...

Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA ...

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

Getting an annual flu shot can be stressful for some people — especially those with autism, fragile X syndrome, ADHD and ...

On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...

1 and KP.2, closely related Omicron sub-lineages that are genetically different than the previously circulating XBB strains, Health Canada said on its website.

1-lineage variants of omicron rather than the XBB.1.5 omicron variant. This is akin to a strain change for a seasonal influenza vaccine. For the Pfizer/BioNTech and Moderna vaccines, this means ...